Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1093095-09-0

C19H16N2O5 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1093095-09-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1093095-09-0 Structure

  • Basic information

    1. Product Name: C19H16N2O5
    2. Synonyms: C19H16N2O5
    3. CAS NO:1093095-09-0
    4. Molecular Formula:
    5. Molecular Weight: 352.346
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1093095-09-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C19H16N2O5(CAS DataBase Reference)
    10. NIST Chemistry Reference: C19H16N2O5(1093095-09-0)
    11. EPA Substance Registry System: C19H16N2O5(1093095-09-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1093095-09-0(Hazardous Substances Data)

1093095-09-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1093095-09-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,0,9 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1093095-09:
(9*1)+(8*0)+(7*9)+(6*3)+(5*0)+(4*9)+(3*5)+(2*0)+(1*9)=150
150 % 10 = 0
So 1093095-09-0 is a valid CAS Registry Number.

1093095-09-0Downstream Products

1093095-09-0Relevant articles and documents

INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER

-

Page/Page column 30, (2009/01/24)

The present invention encompasses compounds of general formula (1) wherein R1 to R4 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition having the above-mentioned properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1093095-09-0